The Pipeline for Digital Analysis of IHC Images from NSCLC Xenograft Tissues
Kandru, R.; Desai, B.
Show abstract
Multiple small molecule inhibitors and immunotherapy advances have shown success by prolonging patients survival in NSCLC but patient with metastasis or advanced stage of cancer often experiences relapse. Cancer associated fibroblast (CAFs), a major cellular component of tumor microenvironment plays key role in shaping solid tumors. In-vitro studies have reported that CAFs can blunt the effect of targeted therapies in tumor cells. The current study focuses on evaluating the impact of stromal protection by analyzing immunohistochemistry (IHC) images from xenograft experiment. The study investigates if the HGF-driven CAF mediated stromal protection in cancer cell contributes to the development of resistance to Alectinib. We utilized QuPath, a digital software to automatize the readout of proliferation rate of tumor cells and evaluate the impact of stromal protection.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring Hypoxia-Related Genes as Prognostic Indicators in Lung Adenocarcinoma 95%
- Machine learning based prediction of recurrence after curative resection for rectal cancer 94%
- Insulin-like Growth Factor 1 Receptor Expression Correlates with Programmed Death Ligand 1 Expression and Poor Survival in Non-small Cell Lung Cancer 94%
Similar papers in this journal
- Patient stratification of clear cell renal cell carcinoma using the global transcription factor activity landscape derived from RNA-seq data 94%
- Systems biomedicine of primary and metastatic colorectal cancer reveals potential therapeutic targets 94%
- miR-100-5p downregulates mTOR to suppress the proliferation, migration and invasion of prostate cancer cells 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Loss of CHGA protein as a potential biomarker for colon cancer diagnosis: a study on biomarker discovery by machine learning and confirmation by immunohistochemistry in colorectal cancer tissue microarrays 94%
- Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics 93%
- A novel molecular analysis approach in colorectal cancer suggests new treatment opportunities 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.